News

14th Invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API evaluation

The following active pharmaceutical ingredient (API) was added:

  • Velpatasvir

 

The following active pharmaceutical ingredient (API) was removed:

  • Simeprevir